NRI Announces Increased Zenagen Hair Loss Product Production and World Wide Beauty Product Demand

Nutraceutical Research Innovations, LLC (NRI)Announces Increased Production of New Zenagen Hair Loss Product Due to Revised Outlook And Distribution For 2010-2011. The International Demand For Zenagen Has Exceed Prior Company Projections.

Online PR News – 29-June-2010 – – Nutraceutical Research Innovations, LLC (N.R.I.) announced increased production of the patent-pending Zenagen hair loss product line, due to increased world-wide demand for the companies blockbuster hair care products. The Miami based nutraceutical company introduced Zenagen hair loss shampoo at the International Beauty and Barber Show Miami in August 2009. The company's nutraceutical division focuses on patent formulations and extraction processes for functional biomolecular compounds.

The Zenagen hair loss line has rapidly expanded its distribution and international presence and has been expanding retail availability through exclusive distribution agreements (

The billion dollar hair loss market has shown rapid growth. Hair loss affects over 80 million people in the US alone, with some studies showing the prevalence of mid-frontal hair loss increases with age and affects 57% of women and 73.5% of men aged 80 and over. The hair loss industry has experienced rapid development over the last 20 years with the introduction of blockbuster FDA approved products Minoxidil (Rogaine)and finasteride (Propecia).

Hair loss also known as adrogenic alopecia, and is thought to be caused by the hormone dihydrotestosterone (DHT) a derivative of testosterone. DHT initiates a process of follicular miniaturization. Through the process of follicular miniaturization, hair shaft width is progressively decreased until scalp hair resembles fragile vellus hair or "peach fuzz" or else becomes non-existent.

Patent-pending Zenagen products use proprietary formulation and extraction techniques using medical grade nutraceutical extracts to reduce, protect, and inhibit the main enzyme of hair loss, 5-alpha reductase.

NRI has recently expanded their focus of hair loss solutions including genetic research and gene therapy and expects to conclude a 3rd party phase 1 research study in early 2011. Learn more about Zenagen at the website

About Zenagen and N.R.I.
Nutraceutical Research Innovations, LLC is a US Based Biotechnology company that develops innovative nutraceutical based products and services. The company research and development team includes medical professionals, biochemical and molecular-biology researchers, and pharmaceutical development specialists. More information can be found at the NRI website

visit our website